{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:47:53Z","timestamp":1790257673039,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Generalitat ValencianaConsejer\u00eda de Educaci\u00f3n Cultura y Deporte","doi-asserted-by":"publisher","award":["CIPROM 2021\/082"],"award-info":[{"award-number":["CIPROM 2021\/082"]}],"id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPU18\/03851"],"award-info":[{"award-number":["FPU18\/03851"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-113388RB-I00"],"award-info":[{"award-number":["PID2020-113388RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MICIU\/AEI\/ 10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/ 10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.lfs.2025.123429","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:10:05Z","timestamp":1738062605000},"page":"123429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Extracellular vesicles from mesenchymal stem cells improve liver injury in rats with mild liver damage. Underlying mechanisms and role of TGF\u03b2"],"prefix":"10.1016","volume":"364","author":[{"given":"Gergana","family":"Mincheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Moreno-Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Felipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Llansola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101133","article-title":"NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123429_bb0010","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1159\/000501851","article-title":"Rodent models of nonalcoholic fatty liver disease","volume":"101","author":"Zhong","year":"2020","journal-title":"Digestion"},{"issue":"7","key":"10.1016\/j.lfs.2025.123429_bb0015","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/liv.14911","article-title":"2021 ISHEN guidelines on animal models of hepatic encephalopathy","volume":"41","author":"DeMorrow","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2025.123429_bb0020","article-title":"Rifaximin prevents T-lymphocytes and macrophages infiltration in cerebellum and restores motor incoordination in rats with mild liver damage","volume":"12;9(8):1002","author":"Balzano","year":"2021","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.lfs.2025.123429_bb0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/biomedicines10061263","article-title":"Rifaximin improves spatial learning and memory impairment in rats with liver damage-associated neuroinflammation","volume":"10","author":"Leone","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-011-9269-3","article-title":"Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy","volume":"27","author":"Felipo","year":"2012","journal-title":"Metab. Brain Dis."},{"issue":"12","key":"10.1016\/j.lfs.2025.123429_bb0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0000000000002498","article-title":"Nonalcoholic fatty liver disease is associated with cognitive function in adults","volume":"86","author":"Seo","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.lfs.2025.123429_bb0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.psym.2018.06.001","article-title":"Cognitive performance in individuals with non-alcoholic fatty liver disease and\/or type 2 diabetes mellitus","volume":"59","author":"Weinstein","year":"2018","journal-title":"Psychosomatics"},{"issue":"13","key":"10.1016\/j.lfs.2025.123429_bb0045","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/jcm10132806","article-title":"A new score unveils a high prevalence of mild cognitive impairment in patients with nonalcoholic fatty liver disease","volume":"10","author":"Gimenez-Garzo","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.lfs.2025.123429_bb0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/egh.09.32","article-title":"Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal","volume":"3","author":"Alkhouri","year":"2009","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2025.123429_bb0055","doi-asserted-by":"crossref","DOI":"10.5604\/01.3001.0010.5498","article-title":"Bile acids in nonalcoholic fatty liver disease: new concepts and therapeutic advances","volume":"16","author":"Cruz-Ram\u00f3n","year":"2017","journal-title":"Ann. Hepatol."},{"issue":"11","key":"10.1016\/j.lfs.2025.123429_bb0060","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/cells10112806","article-title":"Bile acid receptors and the gut-liver axis in nonalcoholic fatty liver disease","volume":"10","author":"Xue","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.lfs.2025.123429_bb0065","article-title":"12\u03b1-Hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats","volume":"1865","author":"Lee","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"3","key":"10.1016\/j.lfs.2025.123429_bb0070","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"Brenner","year":"2013","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123429_bb0075","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jhep.2020.04.033","article-title":"Danger signals in liver injury and restoration of homeostasis","volume":"73","author":"Han","year":"2020","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.lfs.2025.123429_bb0080","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/ijms20071634","article-title":"LOXL2-a new target in antifibrogenic therapy?","volume":"20","author":"Puente","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2025.123429_bb0085","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.7150\/ijbs.83530","article-title":"C-C motif chemokine receptor 2 inhibition reduces liver fibrosis by restoring the immune cell landscape","volume":"19","author":"Guo","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2025.123429_bb0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/cmi.2015.104","article-title":"Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies","volume":"13","author":"Ju","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2025.123429_bb0095","article-title":"Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts","volume":"27;7:F1000 Faculty Rev-921","author":"Weiskirchen","year":"2018","journal-title":"F1000Res"},{"issue":"2","key":"10.1016\/j.lfs.2025.123429_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.22637","article-title":"Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment","volume":"49","author":"Ramm","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lfs.2025.123429_bb0105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3350\/cmh.2022.0327","article-title":"Taurocholic acid promotes hepatic stellate cell activation via S1PR2\/p38 MAPK\/YAP signaling under cholestatic conditions","volume":"29","author":"Yang","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2025.123429_bb0110","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2010.08.028","article-title":"Sphingosine 1-phosphate (S1P)\/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility","volume":"54","author":"Li","year":"2011","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123429_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303296","article-title":"Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis","volume":"19","author":"Osawa","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80010-5","article-title":"The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo","volume":"30","author":"Hellerbrand","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2025.123429_bb0125","article-title":"Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression","volume":"4(1):FSO250","author":"Nallagangula","year":"2017","journal-title":"Future Sci. OA"},{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s13287-022-03001-z","article-title":"Mesenchymal stromal cells: promising treatment for liver cirrhosis","volume":"13","author":"Yao","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.lfs.2025.123429_bb0135","first-page":"8912","article-title":"Transplantation of mesenchymal stem cells expressing TIMP-1-shRNA improves hepatic fibrosis in CCl\u2084-treated rats","volume":"8","author":"Zhu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.lfs.2025.123429_bb0140","article-title":"Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2\/rno-miR-667-5p axis","volume":"13(1):375","author":"Feng","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"22","key":"10.1016\/j.lfs.2025.123429_bb0145","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.3390\/ijms242216086","article-title":"Integrated transcriptome and metabolomics to reveal the mechanism of adipose mesenchymal stem cells in treating liver fibrosis","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2025.123429_bb0150","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2018.01.030","article-title":"Mesenchymal stromal cell therapy for liver diseases","volume":"68","author":"Alfaifi","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2017.09.049","article-title":"Historical perspectives and advances in mesenchymal stem cell research for the treatment of liver diseases","volume":"154","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13287-023-03518-x","article-title":"Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis","volume":"14","author":"Lu","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2025.123429_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108563","article-title":"Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: current perspectives and future challenges","volume":"253","author":"Yadav","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2025.123429_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.594794","article-title":"Molecular pathways modulated by mesenchymal stromal cells and their extracellular vesicles in experimental models of liver fibrosis","volume":"8","author":"Chiabotto","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3350\/cmh.2020.0194","article-title":"The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future","volume":"27","author":"Watanabe","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.lfs.2025.123429_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.865888","article-title":"Mesenchymal stromal\/stem cells and their extracellular vesicles application in acute and chronic inflammatory liver diseases: emphasizing on the anti-fibrotic and immunomodulatory mechanisms","volume":"13","author":"Hazrati","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123429_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114415","article-title":"A review of the effect of exosomes from different cells on liver fibrosis","volume":"161","author":"Hu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.lfs.2025.123429_bb0190","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/liv.15490","article-title":"Extracellular vesicles in fatty liver disease and steatohepatitis: role as biomarkers and therapeutic targets","volume":"43","author":"Eguchi","year":"2023","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13287-023-03364-x","article-title":"Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases","volume":"14","author":"Sani","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2025.123429_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115777","article-title":"Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling","volume":"168","author":"Azizsoltani","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-022-02688-4","article-title":"Extracellular vesicles from mesenchymal stem cells reduce neuroinflammation in hippocampus and restore cognitive function in hype rammonemic rats","volume":"20","author":"Izquierdo-Altarejos","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.lfs.2025.123429_bb0210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jss.2014.06.050","article-title":"Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease","volume":"192","author":"Koeck","year":"2014","journal-title":"J. Surg. Res."},{"issue":"3","key":"10.1016\/j.lfs.2025.123429_bb0215","doi-asserted-by":"crossref","first-page":"527","DOI":"10.20517\/evcna.2024.16","article-title":"Hitting the target: cell signaling pathways modulation by extracellular vesicles","volume":"5","author":"Cerrotti","year":"2024","journal-title":"Extracell Vesicles Circ. Nucl. Acids"},{"issue":"2A","key":"10.1016\/j.lfs.2025.123429_bb0220","first-page":"1029","article-title":"Diagnostic evaluation of carbon tetrachloride-induced rat hepatic cirrhosis model","volume":"25","author":"Lee","year":"2005","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.123429_bb0225","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s13287-024-04076-6","article-title":"Extracellular vesicles from mesenchymal stem cells improve neuroinflammation and neurotransmission in hippocampus and cognitive impairment in rats with mild liver damage and minimal hepatic encephalopathy","volume":"15","author":"Mincheva","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2025.123429_bb0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.reth.2023.04.004","article-title":"(2023). Granulocyte differentiation of rat bone marrow resident C-kit+ hematopoietic stem cells induced by mesenchymal stem cells could be considered as new option in cell-based therapy","volume":"23","author":"Farahzadi","year":"2023","journal-title":"Regen. Ther."},{"issue":"2","key":"10.1016\/j.lfs.2025.123429_bb0235","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1566523221666210519111933","article-title":"Effect of rat bone marrow derived-mesenchymal stem cells on granulocyte differentiation of mononuclear cells as preclinical agent in cell-based therapy","volume":"22","author":"Fathi","year":"2022","journal-title":"Curr. Gene Ther."},{"issue":"2","key":"10.1016\/j.lfs.2025.123429_bb0240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/term.2797","article-title":"Cryopreserved H(2) O(2) -preconditioned human adipose-derived stem cells exhibit fast post-thaw recovery and enhanced bioactivity against oxidative stress","volume":"13","author":"Castro","year":"2019","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.lfs.2025.123429_bb0245","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","article-title":"diaPASEF: parallel accumulation\u2013serial fragmentation combined with data-independent acquisition","volume":"17","author":"Meier","year":"2020","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.lfs.2025.123429_bb0250","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Nonalcoholic steatohepatitis clinical research network","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2025.123429_bb0255","article-title":"The versatility of macrophage heterogeneity in liver fibrosis","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123429_bb0260","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1471-4159.1988.tb03065.x","article-title":"Induction of rat brain tubulin following ammonium ingestion","volume":"51","author":"Felipo","year":"1988","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.lfs.2025.123429_bb0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1373\/jalm.2016.020537","article-title":"Inter-laboratory robustness of next-generation bile acid study in mice and humans: international ring trial involving 12 laboratories","volume":"1","author":"Pham","year":"2016","journal-title":"J. Appl. Lab. Med."},{"issue":"3","key":"10.1016\/j.lfs.2025.123429_bb0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0300-483X(92)90004-X","article-title":"Individual serum bile acids as early indicators of carbon tetrachloride- and chloroform-induced liver injury","volume":"75","author":"Bai","year":"1992","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.lfs.2025.123429_bb0275","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/toxsci\/kfx094","article-title":"Farnesoid X receptor protects against low-dose carbon tetrachloride-induced liver injury through the taurocholate-JNK pathway","volume":"158","author":"Takahashi","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2025.123429_bb0280","first-page":"271","article-title":"Metabolic profiling of endogenous bile acids: a novel method to assess hepatoprotective effect of Tanreqing capsule on carbon-tetrachloride-induced liver injury in rats","volume":"16","author":"Xu","year":"2018","journal-title":"Chin. J. Nat. Med."},{"issue":"6","key":"10.1016\/j.lfs.2025.123429_bb0285","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/hep.30093","article-title":"High mobility group Box-1 drives fibrosis progression signaling via the receptor for advanced glycation end products in mice","volume":"68","author":"Ge","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lfs.2025.123429_bb0290","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/hep.24701","article-title":"Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)beta(3) engagement and PI3K\/pAkt\/NFkappaB signaling","volume":"55","author":"Urtasun","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lfs.2025.123429_bb0295","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/187152809789352230","article-title":"Monocytes and macrophages as cellular targets in liver fibrosis","volume":"8","author":"Heymann","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"12","key":"10.1016\/j.lfs.2025.123429_bb0300","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.3390\/ijms23126649","article-title":"The role of macrophages in liver fibrosis: new therapeutic opportunities","volume":"23","author":"Binatti","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2025.123429_bb0305","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2025.123429_bb0310","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.lfs.2025.123429_bb0315","doi-asserted-by":"crossref","first-page":"563","DOI":"10.21037\/atm.2020.02.163","article-title":"Mesenchymal stem cells to treat liver diseases","volume":"8","author":"Eom","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"13","key":"10.1016\/j.lfs.2025.123429_bb0320","article-title":"Mesenchymal stem cell-derived extracellular vesicles in liver immunity and therapy","volume":"4","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123429_bb0325","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2147\/IJN.S404925","article-title":"Current status and prospect of delivery vehicle based on mesenchymal stem cell-derived exosomes in liver diseases","volume":"18","author":"Lu","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.lfs.2025.123429_bb0330","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s13770-020-00267-3","article-title":"The therapeutic potential of extracellular vesicles versus mesenchymal stem cells in liver damage","volume":"17","author":"Rostom","year":"2020","journal-title":"Tissue Eng. Regen. Med."},{"issue":"6","key":"10.1016\/j.lfs.2025.123429_bb0335","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/scd.2012.0395","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis","volume":"22","author":"Li","year":"2013","journal-title":"Stem Cells Dev."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525000621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525000621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:48:41Z","timestamp":1777441721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525000621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":67,"alternative-id":["S0024320525000621"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123429","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles from mesenchymal stem cells improve liver injury in rats with mild liver damage. Underlying mechanisms and role of TGF\u03b2","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123429"}}